News of the WeekNeurobiology

Fetal Cells Help Parkinson's Patients

Science  29 Oct 1999:
Vol. 286, Issue 5441, pp. 886-887
DOI: 10.1126/science.286.5441.886b

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


MIAMI BEACH, FLORIDA-- A controversial therapy that involves injecting fetal cells into the brains of Parkinson's patients can slow down the progression of the disease, according to the first double-blind, placebo-controlled clinical trial of the procedure. The study, presented here on 24 October at the Society for Neuroscience's annual meeting, shows that the fetal cells can produce a critical neurotransmitter, reducing patients' tremors and paralysis.